Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients

Table 1 Participant demographics

	HC	ME/CFS	Post COVID-19 condition	P-value
Age (years)	39.80 ± 14.77	41.00 ± 9.16	50.80 ± 8.76	0.362
Gender N (%)
Female	4 (80.0%)	3 (60.0%)	3 (60.0%)	0.756
Male	1 (20.0%)	2 (40.0%)	2 (40.0%)
BMI (kg/m²)	23.06 ± 2.80	24.00 ± 3.73	27.82 ± 1.53	0.054
Employment status
Full time	3 (60.0%)	1 (20.0%)	4 (80.0%)	0.113
Part time	1 (20.0%)	0 (0.0%)	0 (0.0%)
Casual	1 (20.0%)	1 (20.0%)	0 (0.0%)
Unemployed	0 (0.0%)	0 (0.0%)	0 (0.0%)
Illness/disability	0 (0.0%)	3 (60.0%)	1 (20.0%)
Education
Primary education	0 (0.0%)	0 (0.0%)	0 (0.0%)	0.364
High school	1 (20.0%)	1 (20.0%)	0 (0.0%)
Undergraduate	2 (40.0%)	2 (40.0%)	2 (40.0%)
Postgraduate/doctoral	2 (40.0%)	2 (40.0%)	1 (20.0%)
Other	0 (0.0%)	0 (0.0%)	2 (40.0%)

Data presented as mean ± SD or N (%). HC healthy control, ME/CFS myalgic encephalomyelitis/chronic fatigue syndrome, BMI body mass index, N number of participants

ISSN: 1528-3658